Login / Signup

Combined PARP and PD-L1 inhibition: a promising treatment option for relapsed small-cell lung cancer.

Naohiro YanagimuraSatoshi WatanabeToshiaki Kikuchi
Published in: Journal of thoracic disease (2024)
Keyphrases
  • small cell lung cancer
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • dna damage
  • diffuse large b cell lymphoma
  • multiple myeloma
  • brain metastases
  • combination therapy